196 related articles for article (PubMed ID: 33885200)
1. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract][Full Text] [Related]
2. Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland.
Bell D; Ferrarotto R; Liang L; Goepfert RP; Li J; Ning J; Broaddus R; Weber RS; El-Naggar AK
Virchows Arch; 2020 Feb; 476(2):295-305. PubMed ID: 31423558
[TBL] [Abstract][Full Text] [Related]
3. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion.
Xu B; Haroon Al Rasheed MR; Antonescu CR; Alex D; Frosina D; Ghossein R; Jungbluth AA; Katabi N
Histopathology; 2020 Feb; 76(3):375-382. PubMed ID: 31448442
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
5. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review.
Sharma P; Sivakumar N; Pandiar D
J Oral Pathol Med; 2023 Mar; 52(3):255-262. PubMed ID: 36207812
[TBL] [Abstract][Full Text] [Related]
7. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M
Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788
[TBL] [Abstract][Full Text] [Related]
8. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma.
Su YJ; Lee YH; Jin YT; Hsieh MS
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):264-272. PubMed ID: 35384876
[TBL] [Abstract][Full Text] [Related]
9. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
[TBL] [Abstract][Full Text] [Related]
10. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: Role of NOR-1 (NR4A3) immunohistochemistry.
Meiklejohn K; Hrones M; Wang M; Prasad ML; Cai G; Adeniran A; Gilani SM
Cytopathology; 2023 May; 34(3):219-224. PubMed ID: 36825365
[TBL] [Abstract][Full Text] [Related]
12. High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation.
Asai S; Sumiyoshi S; Yamada Y; Tateya I; Nagao T; Minamiguchi S; Haga H
Pathol Int; 2021 Jun; 71(6):427-434. PubMed ID: 33848386
[TBL] [Abstract][Full Text] [Related]
13. NOR-1 (NR4A3) immunostaining on cytologic preparations for the preoperative diagnosis of acinic cell carcinoma of the salivary gland.
Krishnan V; Nguyen L; Shen R; Lieu D; De Peralta-Venturina M; Fan X
J Am Soc Cytopathol; 2022; 11(6):352-358. PubMed ID: 36058827
[TBL] [Abstract][Full Text] [Related]
14. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
[TBL] [Abstract][Full Text] [Related]
15. Utility of MUC4 in the diagnosis of secretory carcinoma of salivary glands.
Fatima S; Ahmed A; Suleman S; Din NU
Ann Diagn Pathol; 2023 Dec; 67():152220. PubMed ID: 37924657
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
Skaugen JM; Seethala RR; Chiosea SI; Landau MS
Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
[TBL] [Abstract][Full Text] [Related]
17. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
[TBL] [Abstract][Full Text] [Related]
18. NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens.
Nguyen L; Chopra S; Laskar DB; Rao J; Lieu D; Chung F; Kim ED; de Peralta-Venturina M; Bose S; Balzer B
Hum Pathol; 2020 Aug; 102():1-6. PubMed ID: 32416209
[TBL] [Abstract][Full Text] [Related]
19. Cytopathological features of secretory carcinoma of salivary glands and ancillary techniques in its diagnostics: impact of new Milan system for reporting salivary gland cytopathology.
Miesbauerová M; Tommola S; Šteiner P; Baněčková M; Skálová A; Kholová I
APMIS; 2019 Jul; 127(7):491-502. PubMed ID: 30942913
[TBL] [Abstract][Full Text] [Related]
20. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
